Rivastigmine 13.3mg/24h transdermal patch (Voleze®)
Shared care guideline available
-
Traffic LightAmber (SCG)
-
Licensed IndicatorsMild to moderate severe alzhemiers disease
-
ReferenceAPC Jan 15
-
ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?